Table 6.
Trend analysis for the top 10 cancer types in 2011–2015 in Shenzhen during 2001–2015 (males).
| ASR-China (1/105) † | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | All cancers | Lung | Liver | Colorectal | Stomach | Thyroid Gland | Nasopharynx | Prostate | Leukemia | Lymphoma | Bladder |
| 2001 | 145.79 | 31.75 | 21.57 | 20.15 | 13.50 | 0.95 | 10.64 | 2.76 | 5.23 | 4.24 | 4.69 |
| 2002 | 159.91 | 31.54 | 28.15 | 19.51 | 16.09 | 1.53 | 12.02 | 2.94 | 7.82 | 3.99 | 3.36 |
| 2003 | 185.98 | 39.90 | 29.45 | 19.15 | 17.17 | 1.59 | 11.39 | 5.52 | 8.46 | 5.55 | 4.25 |
| 2004 | 171.20 | 31.68 | 27.79 | 22.60 | 17.17 | 1.85 | 11.42 | 5.12 | 7.18 | 4.95 | 5.36 |
| 2005 | 196.65 | 38.37 | 30.88 | 24.42 | 15.62 | 2.12 | 13.10 | 6.33 | 6.45 | 6.61 | 7.70 |
| 2006 | 154.95 | 27.99 | 21.36 | 21.80 | 12.20 | 2.21 | 8.77 | 5.57 | 7.71 | 6.10 | 3.70 |
| 2007 | 183.18 | 38.08 | 27.45 | 23.29 | 13.21 | 3.19 | 9.28 | 6.48 | 7.17 | 5.44 | 5.63 |
| 2008 | 180.45 | 33.18 | 27.31 | 21.84 | 11.77 | 2.77 | 8.12 | 7.12 | 9.66 | 6.08 | 6.52 |
| 2009 | 175.32 | 32.78 | 26.11 | 25.25 | 14.55 | 4.30 | 8.45 | 7.09 | 8.24 | 6.41 | 4.93 |
| 2010 | 197.65 | 38.91 | 26.45 | 25.92 | 13.58 | 3.50 | 8.97 | 8.29 | 8.96 | 9.10 | 6.13 |
| 2011 | 168.78 | 34.32 | 21.75 | 23.17 | 11.53 | 2.97 | 7.22 | 8.85 | 8.85 | 5.13 | 5.98 |
| 2012 | 206.81 | 36.44 | 30.43 | 29.02 | 16.22 | 6.06 | 10.04 | 10.34 | 9.46 | 7.92 | 6.11 |
| 2013 | 185.53 | 35.73 | 24.89 | 26.13 | 11.36 | 10.05 | 6.58 | 9.15 | 8.26 | 7.16 | 5.92 |
| 2014 | 166.05 | 32.47 | 20.41 | 22.44 | 9.57 | 9.20 | 5.66 | 9.28 | 7.18 | 8.15 | 4.88 |
| 2015 | 186.72 | 37.91 | 21.98 | 25.59 | 13.85 | 10.60 | 7.00 | 10.97 | 8.73 | 7.84 | 5.58 |
| APC (%) ‡ | 0.96 | 0.57 | –1.05 | 1.92 * | –2.06 * | 16.95 * | –4.38 * | 41.70 * (2001–2003) | 1.96 * | 4.36 * | 2.08 |
| 6.68 * (2003–2015) | |||||||||||
† = age-standardized incidence rate (China population, 1982); ‡ = annual percent change of ASR-China; and * The APC is significantly different from zero at alpha = 0.05.